Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

MACLEODS PHARMACEUTICALS LTD

Active

MACLEODS PHARMACEUTICALS LTD having CIN U24239MH1989PLC052049 is 36 years & 3 days old Public Indian Company incorporated on 05 Jun 1989. It is classified as Non-government company and is registered at ROC Mumbai. Its authorized share capital is Rs. 650,000,000 and its paid up capital is Rs. 648,722,100. It's NIC code is 24239 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc. . MACLEODS PHARMACEUTICALS LTD Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2023. Directors of MACLEODS PHARMACEUTICALS LTD are Rajesh kumar Mittal and Vinita Mayur Danait.

MACLEODS PHARMACEUTICALS LTD ' Corporate Identification Number (CIN) is U24239MH1989PLC052049 and its registration number is 052049. Users may contact MACLEODS PHARMACEUTICALS LTD on its Email address - roc@macleodspharma.com Registered address of MACLEODS PHARMACEUTICALS LTD is 304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST),MUMBAI,Maharashtra,India-400059. Current status of MACLEODS PHARMACEUTICALS LTD is - Active.

Key Indicators

Authorised Capital
650,000,000

as on 08/06/2025

Paid Up Capital
648,722,100

as on 08/06/2025

Company Age
36 Year, 0 Months
Last Filing with ROC
1 Year, 8 Months

Company Information

CIN U24239MH1989PLC052049
Company Status Active
Registration Number 052049
Date of Incorporation 06/05/1989
RoC ROC Mumbai
Company Age 36 years & 12 days
Authorized Capital ₹ 650000000
Paid-up capital ₹ 648722100
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Public
Activity Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc.
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID roc@macleodspharma.com
Address 304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) MUMBAI Maharashtra India 400059
Website macleodspharma.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
BANWARILAL MURLIDHAR BAWRI
04/18/2023 00017795 *****1114E 2 years
Director
GIRDHARILAL MURLIDHAR BAWRI
06/26/2024 00034197 *****7048L 0 years
Director
MIHIR BIPIN SHAH
02/03/2022 07586469 *****4663A 3 years
Director
ARVIND SADASHIV MOKASHI
08/28/2023 09305967 *****6145K 1 years
Director
VINITA MAYUR DANAIT
07/21/2023 00216529 *****3598E 1 years
Director
VINAYAK VASUDEV SHIRODKAR
03/20/2023 00131777 *****7254R 2 years
Director
VIJAY GIRDHARILAL AGARWAL
02/09/2022 10397576 *****0609D 3 years
Director
RAJENDRA MURLIDHAR AGARWAL
06/18/2024 00034224 *****9611N 0 years
Director
LALIT KUMAR SINGAL
04/04/2023 03586738 *****6550L 2 years
Director
RAJESH KUMAR MITTAL
03/31/2023 02885112 *****2385G 2 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
MACLEODS LABORATORIES PRIVATE LIMITED
Active
1,21,300.00 2 Maharashtra
EAST AND WEST CLOTHING PRIVATE LIMITED
Active
15,00,000.00 2 Maharashtra
AGARWAL HOLDINGS PRIVATE LIMITED
Active
19,96,06,800.00 2 Maharashtra
TERRACIS TECHNOLOGIES LIMITED
Active
11,21,72,710.00 2 Maharashtra
INDIA DEBT RESOLUTION COMPANY LIMITED
Active
20,00,00,000.00 2 Maharashtra
KAN CONSULTANCY SOLUTIONS PRIVATE LIMITED
Strike Off
7,48,000.00 2 Maharashtra
LANCE FINANCIAL CONSULTANTS PRIVATE LIMITED
Active
10,67,000.00 2 Maharashtra
GENRX PHARMACEUTICALS PRIVATE LIMITED
Under Liquidation
1,00,00,000.00 1 Maharashtra
R.S. MITTAL CONSULTANTS PRIVATE LIMITED
Active
1,00,000.00 1 Maharashtra
JAIN IRRIGATION SYSTEMS LIMITED
Active
1,37,35,23,730.00 2 Maharashtra

Charges on assets

1

Others

No. of Loans: 1

Total Amount: 619,225,000.00 cr

2

State Bank of India

No. of Loans: 1

Total Amount: 2,997,000,000.00 cr

3

Standard Chartered Bank

No. of Loans: 1

Total Amount: 715,000,000.00 cr

4

HDFC BANK LIMITED

No. of Loans: 1

Total Amount: 599,250,000.00 cr

5

Axis Bank Limited

No. of Loans: 1

Total Amount: 500,000,000.00 cr

6

ICICI BANK LTD.

No. of Loans: 4

Total Amount: 77,630,000.00 cr

7

CITI BANK N.A.

No. of Loans: 1

Total Amount: 600,000,000.00 cr

8

STATE BANK OF INDIA

No. of Loans: 2

Total Amount: 19,500,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
Others Mahakali Caves Road, Andheri East 619,225,000 26 Apr, 2021 02 Nov, 2021 04 Mar, 2023 Closed
State Bank of India S V Road,Near Chincholi Signal, Malad West 2,997,000,000 07 Sep, 2020 07 Dec, 2021 - Open
Standard Chartered Bank 23 Barakhamba Road 715,000,000 31 Jul, 2021 - - Open
HDFC BANK LIMITED LOWER PAREL W 599,250,000 21 Jun, 2021 - - Open
Axis Bank Limited A -Wing - First Floor, Nariman Point 500,000,000 26 Apr, 2021 - - Open
ICICI BANK LTD. L. T. ROAD, OPP. SHRI SAGAR HOTEL 15,460,000 19 Sep, 2013 - 04 Apr, 2019 Closed
CITI BANK N.A. Bandra Kurla Complex 600,000,000 29 Nov, 2006 05 Mar, 2012 09 Aug, 2012 Closed
STATE BANK OF INDIA 13,020,000 22 Mar, 1994 - 17 Feb, 2006 Closed
ICICI BANK LTD. L. T. ROAD, OPP. SHRI SAGAR HOTEL 22,160,000 19 Sep, 2013 - 04 Apr, 2019 Closed
ICICI BANK LTD. L. T. ROAD, OPP. SHRI SAGAR HOTEL 22,160,000 19 Sep, 2013 - 04 Apr, 2019 Closed
ICICI BANK LTD. L. T. ROAD, OPP. SHRI SAGAR HOTEL 17,850,000 19 Sep, 2013 - 04 Apr, 2019 Closed
STATE BANK OF INDIA 6,480,000 09 Aug, 1990 - 17 Feb, 2006 Closed

Registered Details

CIN
U24239MH1989PLC052049
PAN
U24239MH1989PLC052049
Incorporation
2 years , 2 month
Company Email
roc@macleodspharma.com
Paid up Capital
₹ 648,722,100
Authorised Capital
₹ 650,000,000
Type
Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc.

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Macleods Pharmaceuticals Ltd

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Macleods Pharmaceuticals Ltd

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Macleods Pharmaceuticals Ltd

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Macleods Pharmaceuticals Ltd

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Macleods Pharmaceuticals Ltd

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Macleods Pharmaceuticals Ltd

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Macleods Pharmaceuticals Ltd

What is MACLEODS PHARMACEUTICALS LTD ?

MACLEODS PHARMACEUTICALS LTD having CIN U24239MH1989PLC052049 is 2 years , 2 month old Public Indian Company incorporated with MCA on 31 Mar 2023. MACLEODS PHARMACEUTICALS LTD is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Mumbai with an Authorized Share Capital of 650,000,000 and paid-up capital is 648,722,100.

What is the CIN of MACLEODS PHARMACEUTICALS LTD?

CIN of MACLEODS PHARMACEUTICALS LTD is U24239MH1989PLC052049.

Where is MACLEODS PHARMACEUTICALS LTD located?

Address of MACLEODS PHARMACEUTICALS LTD is 304, atlanta arcade, marol church road, andheri (east),mumbai,maharashtra,india-400059,.

Who are the directors of MACLEODS PHARMACEUTICALS LTD ?

The company has 18 directors/key management personnel Banwarilal Bawri,girdharilal Bawri,mihir Shah,arvind Mokashi,vinita Danait,vinayak Shirodkar,vijay Agarwal,u24239mh1989plc052049 U24239mh1989plc052049,rajendra Agarwal,siddhesh Rane,banwarilal Bawri,lalit Singal,rajesh Kumar Mittal,vinayak Shirodkar,girdharilal Bawri,rajendra Agarwal,arvind Mokashi,vinita Danait,

What is the contact details of MACLEODS PHARMACEUTICALS LTD ?

Email : roc@macleodspharma.com
Address : 304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) MUMBAI Maharashtra India 400059

What does MACLEODS PHARMACEUTICALS LTD do?

MACLEODS PHARMACEUTICALS LTD is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry